-
AIPLA CLE Webinar: Post-Grant Strategies for Correcting and Challenging Patent Claims
March 4, 2020 12:30 PM to 2:00 PM | 1.5 CLE Credits
This webinar will provide a summary of post-grant procedures and describe when, why, and how each procedure is useful (or not) to patent owners and third-party challengers.
-
AIPLA CLE Webinar: Post-Grant Strategies for Correcting and Challenging Patent Claims
March 4, 2020 12:30 PM to 2:00 PM | 1.5 CLE Credits
This webinar will provide a summary of post-grant procedures and describe when, why, and how each procedure is useful (or not) to patent owners and third-party challengers.
-
AIPLA CLE Webinar: Post-Grant Strategies for Correcting and Challenging Patent Claims
March 4, 2020 12:30 PM to 2:00 PM | 1.5 CLE Credits
This webinar will provide a summary of post-grant procedures and describe when, why, and how each procedure is useful (or not) to patent owners and third-party challengers.
News
-
.png?sfvrsn=9d645e3f_0 "USPTO")
USPTO Offers Free Oral Advocacy Training Under the Legal Experience and Advancement Program
May 14, 2020
The Patent Trial and Appeal Board’s (PTAB) first Legal Experience and Advancement Program (LEAP) webinar on oral advocacy will take place today, Thursday, May 14, from noon to 1 p.m. ET. -
National Geographic Wins in ‘Wild America’ Show Trademark Case
May 13, 2020
National Geographic Partners LLC beat back trademark infringement claims by the makers of the PBS nature series “Wild America” after a federal court in Colorado found National Geographic TV had an artistic motive for naming its nature show “Untamed Americas.” -
Slayback Beats Eagle’s Leukemia Drug Patent Claims at Fed. Cir.
May 12, 2020
The Federal Circuit on May 8, 2020, affirmed a lower court ruling that found that Slayback Pharma LLC’s generic version of the leukemia drug Belrapzo didn’t infringe four Eagle Pharmaceuticals Inc. patents because the drugs weren’t the same under patent law. -
USPTO Announces COVID-19 Prioritized Examination Pilot Program for Small Entities
May 11, 2020
The United States Patent and Trademark Office (USPTO) on May 8, 2020, announced a new COVID-19 Prioritized Examination Pilot Program. -
USPTO Allows Filing of Plant Patent Applications Via Electronic Filing Systems
May 8, 2020
In response to the COVID-19 outbreak, the United States Patent and Trademark Office (USPTO) announced that it will temporarily permit the filing of plant patent applications and follow-on documents via the USPTO patent electronic filing systems (EFS-Web or Patent Center) until further notice.